Assay Menu Expansion
Various (e.g., Endocrinology, Inflammation)
Key Facts
About DRG International
DRG International is a well-established, revenue-generating diagnostics company specializing in immunoassay development, manufacturing, and distribution. Its core offerings include ELISA kits for areas like autoimmune diseases, cancer, cardiac markers, and infectious diseases, alongside the DRG:HYBRiD-XL automated analyzer and distribution of CHROMagar media. Acquired by BioCheck, Inc. in 2021, the company leverages ISO 13485:2016 and MDSAP certifications to serve a broad international market through a direct and distributor network. Its strategy focuses on providing accessible, high-quality diagnostic tools to enable earlier treatment intervention.
View full company profileAbout Immunodiagnostic Systems
IDS PLC is a long-established, revenue-generating diagnostics company specializing in immunoassays and automated instruments. It operates globally, providing solutions for both human clinical diagnostics and translational animal research, with a particular noted strength in bone and cartilage metabolism markers. The company is now visibly integrated into the Euroimmun group, suggesting a recent acquisition or strategic merger that expands its reach and resources within the PerkinElmer/Euroimmun diagnostic network.
View full company profileAbout Orgentec Diagnostics
Orgentec Diagnostika is a well-established, revenue-generating diagnostics company with a 35+ year history in autoimmune and infectious disease testing. Its core business revolves around the Alegria® automated ELISA platform and associated test kits and reagents. As part of the Sebia Group since its acquisition, Orgentec benefits from enhanced commercial scale and resources while navigating integration and a competitive, innovation-driven market.
View full company profile